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Abstract The field of noninvasive cardiac imaging has
experienced enormous advances including computerized
tomography coronary angiography (CTCA). Invasive
angiography remains the anatomic standard of reference but
it is associated with a non-negligible peri-procedural mor-
bidity and mortality which suggests confining its use to
patients who will benefit from a revascularization proce-
dure. Many factors that are beyond the simple quantification
of diameter narrowing and therefore cannot be fully asses-
sed with luminology will eventually determine whether or
not a given lesion produces stress-induced ischemia. Myo-
cardial perfusion scintigraphy by single photon emission
computerized tomography (SPECT) is one of the most
widely used and well established noninvasive tools for the
diagnosis of ischemic heart disease. Although positron
emission tomography (PET) offers a higher accuracy than
SPECT its use is often limited to large centers. This article
explains the great potential of cardiac hybrid imaging which
allows a comprehensive evaluation of coronary artery dis-
ease as it combines both morphological and functional
information by fusing either SPECT or PET with CTCA.
SPECT/CT and PET/CT hybrid imaging can provide
entirely noninvasively unique information which helps
improving diagnostic assessment and risk stratification and
also impacts decision making with regard to revasculari-
zation in patients with coronary artery disease.
Keywords Hybrid cardiac imaging  SPECT/CT 
PET/CT  Nuclear cardiology
Coronary stenoses and ischemic heart disease:
two faces of the same coin
Despite the trend in modern medicine away from inter-
vention towards prevention the treatment of coronary artery
disease has remained of great importance in industrialized
countries. Although invasive coronary angiography is
affected by a considerable morbidity (1.5%) [1] and mor-
tality (0.3%) [2] this has remained the most established
method for visualization of the coronary arteries and, thus,
the standard of reference for the diagnosis of coronary
stenoses. It is, however, far from being a perfect diagnostic
tool as in fact its accuracy is severely hampered by a large
intraobserver and interobserver variability in defining the
anatomic relevance of stenoses (up to 50%) [3, 4]. This
is further underlined by the fact that invasive coronary
angiography is very poorly correlated with postmortem
coronary anatomy [5, 6]. Most importantly, angiographic
findings are poor predictors of physiologic relevance of a
coronary stenosis [4, 7–10]. A substantial fraction—namely
between 20 and 40%—of all diagnostic invasive coronary
angiograms reveal clinically insignificant disease [1]. This
has lead to a search for strategies for non-invasive coronary
imaging, among them dichromatic synchrotron radiation
[11], electron beam tomography [12], magnetic resonance
imaging [13, 14], and multidetector computerized tomog-
raphy coronary angiography (CTCA) [15]. Only the latter
has recently emerged as an acceptable alternative to the
The University Hospital Zurich holds a research contract with GE
Healthcare (Milwaukee, WI, USA).
P. A. Kaufmann (&)
Cardiac Imaging, University Hospital Zurich,
NUK C 42, Raemistrasse 100, 8091 Zurich, Switzerland
e-mail: pak@usz.ch
P. A. Kaufmann
Zurich Center for Integrative Human Physiology (ZIHP),
University of Zurich, Zurich, Switzerland
123
Ann Nucl Med (2009) 23:325–331
DOI 10.1007/s12149-009-0245-5
invasive coronary angiography for visualization of the
coronary anatomy.
It is very likely, but still awaits confirmation in large
multicenter trials, that CTCA will help to change the fact
that at present only about a third of patients referred to
catheterization will eventually undergo a revascularization
procedure [16] leaving most of the patients exposed to the
risks but without the benefit of a catheter in their coronary
arteries. Coronary anatomy, however, may not allow to
estimate with certainty the pathophysiologic relevance of a
coronary lesion, as particularly in intermediate lesions
there are many factors influencing the interrelation between
anatomic finding and hemodynamic consequences which
cannot be fully elucidated by anatomic evaluation alone,
not even with the use of quantitative coronary angiography
[17]. Therefore, according to the actual European and
American guidelines a test for ischemia before any elective
coronary angiography is mandatory [18–20]. It appears,
however, that there is still a large gap between these evi-
dence-based guidelines and the daily clinical routine, as
underlined by a recent study by Lin et al. reporting that in a
large cohort of patients (n = 23887) referred for elective
coronary intervention only a minority (44%) had under-
gone any kind of stress testing in a 90-day period prior to
the intervention [21]. This impressively underlines the need
to increase both the awareness of the importance and the
availability of non-invasive testing for coronary artery
disease.
Role of single photon emission computerized
tomography (SPECT)
Nuclear myocardial perfusion imaging (MPI) with SPECT
represents the most widely available, robust and by far best
established non-invasive method for this purpose [22],
while coronary angiography has remained the standard of
reference for the anatomy of the epicardial coronary artery
anatomy. A perfect agreement of MPI SPECT and coro-
nary angiography cannot be expected and is not a main
prerequisite for its clinical value. In the non-invasive
diagnostic algorithm the main role of SPECT is not to
correctly predict or exclude epicardial coronary lesions but
rather to evaluate the physiological relevance of known or
suspected coronary stenoses. Nevertheless, as invasive
coronary angiography is the generally accepted standard of
reference for coronary lesions the findings of functional
tests including SPECT have often been compared to those
of coronary angiography. The results may depend at least
in part from the size and selection of the study population.
One of the largest recent reports, the British ROBUST-
study, included 2560 patients who were randomized to one
of the commonly used tracers (Thallium, Sestamibi or
Tetrofosmin) applying mainly adenosine stress. The
authors found a sensitivity of 91% and a specificity of 87%
without differences between the tracers [23].
Role of positron emission tomography (PET)
The most important perfusion tracers for clinical PET are
N-13-ammonia and—mainly in the US—Rubidium-82.
Several studies involving over 1400 patients have recently
been included in a meta-analysis which confirmed the high
sensitivity and specificity of PET MPI. The use of Rubid-
ium-82 offers the advantage that there is no need of any
cyclotron. By contrast, the application of N-13-ammonia
and alternatively of O-15-water requires an on-site cyclo-
tron due to the short half lives (i.e. 10 min and 2 min,
respectively). This major drawback seems to be responsible
for the fact that this technique has not gained wide
acceptance in the clinical arena. Theoretically, O-15-water
may appear to be the ideal myocardial perfusion tracer as it
diffuses almost freely through cell membranes. Unfortu-
nately it does not allow achieving a strong signal-to-noise
ratio between the myocardium and the ventricular blood
pool due to the lack of accumulation into the myocytes
which precludes obtaining clinically meaningful perfusion
images. Therefore, application of O-15-water can only
provide useful information if postprocessing with quanti-
tative evaluation is performed. As this is a relative complex
procedure O-15-water has mainly remained confined to
scientific applications [24]. As long as an on-site cyclotron
is available N-13-ammonia has remained the perfusion
tracer of choice because it provides high-quality perfusion
images for visual analysis for daily clinical routine and at
the same time also allows quantification of global and
regional myocardial perfusion. Because PET confers a
higher resolution than SPECT and inherently uses attenu-
ation correction there is a general expert consensus that
sensitivity and specificity of PET is superior to that of
SPECT although this perception is not based on a large
number of patients studied in head-to-head comparisons
between SPECT and PET. Finally, it remains to be eluci-
dated whether the higher costs of PET will be justified by
the improvement of accuracy compared to SPECT.
Definition and general aspects of hybrid imaging
The consideration of the duality of morphology and function
has gained importance over the last few years. This has lead
to the conviction that comprehensive assessment of coro-
nary disease should include both, information on coronary
lesion morphology and on myocardial perfusion. Non-
invasive assessment of myocardial perfusion scintigraphy
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has been available for more than three decades. By contrast
non-invasive coronary angiography has only been intro-
duced recently into the clinical arena after the advent of
multi-detector computed tomography [15]. The latter tech-
nology has finally met the requirements with regard to
temporal and spatial resolution to allow clinical use. This
has provided the base for combination of CTCA with
complementary nuclear modalities into hybrid imaging. In
addition to the developments in non-invasive CTCA
advances in image processing software (Fig. 1a, b) [25] and
the introduction of hybrid scanners have paved the way for
integrating image data sets from different modalities into
hybrid images. Such software reliably allows superposition
of myocardial segments depicted by SPECT or PET onto
cardiac CT anatomy, resulting in an easily interpretable
panoramic view of the heart, which integrates the high-
resolution 3-dimensional information of the coronary
arteries with the functional information of the SPECT
perfusion image (Fig. 1c, d). Despite the integration of high-
end CT devices with the capability to perform state-of-the-
art coronary CT angiography into nuclear scanners to form
dedicated cardiac hybrid scanners, manual image coregis-
tration may remain indispensable. Studies with X-ray based
attenuation correction have reported that automated coreg-
istration of CT and SPECT images is often unreliable and
manual correction for misalignment is needed in the vast
majority of the cases [26, 27]. Dedicated cardiac fusion
software packages are now commercially available allowing
software-based hybrid imaging with an excellent interob-
server reproducibility and short processing durations [25].
Although fusion of invasive coronary angiography with
SPECT has been attempted in the past, the warping and 3-
dimensional unification by forcing a planar 2-dimensional
angiogram into a fusion with a 3-dimensional perfusion
scan data set provided technically unsatisfying results. In
addition, such approach precludes non-invasive preplan-
ning of the intervention as the information on the coronary
anatomy is obtained by invasive coronary angiography.
During such procedure, however, rapid decision making
should not be delayed by the need of time consuming
offline analyses. This drawback may explain why this
concept which does not allow careful non-invasive plan-
ning of the elective intervention has not been adopted into
daily clinical routine.
At this point it should be clarified that the definition of
hybrid imaging is the combination and fusing of two
imaging data stets by which both modalities equally con-
tribute to image information [28]. This is important as the
term hybrid imaging has also been used in different con-
texts potentially raising some confusion about its exact
meaning. For example, some authors have used the term
hybrid imaging for X-ray based attenuation correction
although in such setting the CT images do not provide
neither anatomical nor functional information but rather
exclusively contribute to improve image quality of the
other modality (PET or SPECT). In fact, the parametric
maps obtained from low-dose CT do not provide image
information beyond that needed for attenuation correction
[26, 29]. This is underlined by the fact that Ge-68 sources
used in the previous generation of PET scanners provided
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the same information, but such type of imaging was not
perceived as hybrid imaging as attenuation correction does
not contribute to topographic image information. Others
have used the term ‘‘hybrid imaging’’ for the side-by-side
analysis of MPI and CT images [30]. To avoid confusion,
we suggest using the term hybrid imaging for any combi-
nation of structural and functional information beyond that
offered by attenuation correction or side-by-side analysis,
i.e. fusion of two separate data sets into one image
(Fig. 1d). Thus, this definition would not include attenua-
tion corrected images without integrating anatomical
information. Similarly, separate acquisition of structural
information as well as functional (for example perfusion)
data on two separate scanners or on one hybrid device
would allow mental integration of side-by-side evaluation
but only fusion of both pieces of information would result
in a hybrid image.
Role of hybrid imaging: implications and limitations
The continuing rapid evolution of CTCA suggests that,
when combined with perfusion imaging, it has the potential
to be implemented into clinical practice. As mentioned
above the advancements in fast-processing software for 3-
dimensional reconstructions have allowed initial promising
attempts of purely noninvasive CAD assessment directly
relating individual myocardial wall territories with
impaired myocardial perfusion to the subtending coronary
artery by use of PET and CT [31]. Recent data using
SPECT and CT suggest that hybrid imaging provides added
diagnostic clinical value beyond that of either technique
alone or that of side-by-side analysis [28, 32, 33]. The
added value seems to be found on both sides of the diag-
nostic spectrum, i.e. in low risk populations [34] as well as
in those with multi-vessel disease [33]. In low risk popu-
lations hybrid imaging may increase the confidence to rule
out coronary artery disease for example in the stepwise
evaluation of coronary artery disease when the first study
has yielded equivocal results and a second modality is
needed to finally rule out with certainty any disease. Many
of those patients would end up with invasive coronary
angiography while hybrid imaging increases diagnostic
confidence by avoiding equivocal findings which helps to
reduce the number of patients unnecessarily exposed to the
non-negligible risks of morbidity and mortality [2] asso-
ciated with invasive coronary procedures. A the other end
of the spectrum, i.e. in patients who are older then those
mentioned above and who often suffer from multivessel
disease with more jeopardized myocardium, hybrid imag-
ing provides important comprehensive information to
allow for timely and appropriate treatment. In such setting
the value of hybrid imaging lies far beyond the simple
addition of a further diagnostic test as it allows accurate
spatial association of perfusion defects to their subtending
coronary stenosis (Fig. 2; [35]). Hybrid imaging is a
completely non-invasive approach to coronary artery dis-
ease which allows obtaining important information prior to
any invasive procedure and provides the detailed infor-
mation for evidence driven intervention targeting relevant
lesion only. Although the CT part of hybrid imaging has
excellent abilities in ruling out hemodynamic relevant
coronary artery disease, an abnormal CTCA—like an
abnormal conventional angiography study—is a poor pre-
dictor of ischemia, and further perfusion imaging testing is
warranted to identify those patients who might benefit from
a revascularization procedure [36, 37] and those in whom
conservative management and risk modification may be
justified [38]. Conversely, a normal MPI result does not
exclude the presence of subclinical coronary disease as
assessable with CTCA and conventional coronary angiog-
raphy for which aggressive cardiovascular risk modifica-
tion may be warranted. The incongruence of CTCA and
MPI is inherent to the duality of morphologic versus
functional testing. The technologic refinements imple-
mented in the latest CT scanner generations have reduced
the number of non-evaluable coronary segments and fur-
ther improvements may be expected. However, no matter
how accurate CTCA will possibly get with future advances
in technology, the two pieces of information obtained with
perfusion imaging versus morphology are difficult to
compare. This has been recently documented by Gaemperli
et al. who found that the receiver operator characteristic
analysis for detection of perfusion defects (by SPECT)
showed similar area under the curves for the reference
standard, conventional angiography, and for CT angiogra-
phy, documenting comparable performance and limitations
of both anatomic morphologic techniques [39]. Hence,
many factors that are beyond the simple quantification of
diameter narrowing and that therefore cannot be fully
assessed with luminology will eventually determine whe-
ther or not a given lesion produces stress-induced ischemia.
First clinical results from our institution appear
encouraging, and support that hybrid images offer superior
diagnostic information with regard to identification of the
culprit vessel with the hemodynamic relevant lesion and
increases diagnostic confidence for categorizing interme-
diate lesions and equivocal perfusion defects as in almost
one-third of patients the fused analysis provided added
diagnostic information not obtained on side-by-side anal-
ysis [33]. The incremental value seems most pronounced
for functionally relevant lesions in distal segments and
diagonal branches and in vessels with extensive coronary
lesions or heavy calcifications on CTCA. Other groups
have confirmed the added value of hybrid cardiac imaging
[40]. Results from a first multicenter study underline the
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value of a combined functional and anatomical approach
even without hybrid imaging showing that this combina-
tion allows improved risk stratification [41]. The clinical
usefulness in terms of impact on treatment strategy and
subsequently on outcome by hybrid imaging remains,
however, to be determined in prospective and long-term
studies. Similarly, it remains uncertain at this point whether
hybrid scanners offer advantages over software fusion of
data sets obtained from different scanners, as by either way
one can obtain hybrid images [28]. The scan time dis-
crepancy between emission from nuclear and CT trans-
mission determines that high-end CT facilities constituting
the CT component of hybrid cardiac scanners will be
blocked by long emission scan time and is therefore forced
to operate at low capacity. On the other hand, a combined
device may fit into one room and needs one operating
team and does not require positioning of the patient
into two different scanners. The development of ultrafast
SPECT scanners allowing substantially shorter acquisition
time may shift the balance towards hybrid scanners in the
future.
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